TY - JOUR
T1 - Prenatal IgE as a Risk Factor for the Development of Childhood Neurodevelopmental Disorders
AU - Straughen, Jennifer K.
AU - Sitarik, Alexandra R.
AU - Johnson, Christine Cole
AU - Wegienka, Ganesa
AU - Ownby, Dennis R.
AU - Johnson-Hooper, Tisa M.
AU - Allo, Ghassan
AU - Levin, Albert M.
AU - Cassidy-Bushrow, Andrea E.
N1 - Funding Information:
This study was supported by the National Institutes of Health (R01 AI050681, R01 HL113010, R01 HD082147, and P01 AI089473), the Fund for Henry Ford Hospital, and the Department of Defense (AR180175).
Publisher Copyright:
© Copyright © 2021 Straughen, Sitarik, Johnson, Wegienka, Ownby, Johnson-Hooper, Allo, Levin and Cassidy-Bushrow.
PY - 2021/5/14
Y1 - 2021/5/14
N2 - Background: Few studies have examined if maternal allergic disease is associated with an offspring's neurodevelopment. We hypothesized that Th-2 biased maternal immune function assessed as total serum immunoglobulin (Ig) E is associated with attention deficit hyperactivity disorder (ADHD). Methods: Data are from the Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study (WHEALS), a racially and socioeconomically diverse birth cohort in metropolitan Detroit, Michigan. Maternal total IgE was measured prenatally and at 1-month postpartum. Child total IgE was assessed at birth, 6 months, and 2 years of age. ADHD diagnosis was based on the parental report at the 10–12-year study visits or medical chart abstraction. Total IgE was log2 transformed. Poisson regression models with robust error variance were used to calculate the risk ratios (RR). Inverse probability weighting was used to correct for potential bias due to a loss to follow-up and non-response. Results: Of the 636 maternal-child pairs in the analysis, 513 children were neurotypical and 123 had ADHD. Maternal prenatal total IgE was significantly associated with ADHD even after adjustment for potential confounders (RR = 1.08, 95% CI 1.03–1.13). Maternal and child IgE measures were positively and significantly correlated, but child total IgE was not associated with ADHD at any time point. Conclusions: Maternal prenatal IgE may influence neurodevelopment, but additional studies are needed to confirm and expand these findings.
AB - Background: Few studies have examined if maternal allergic disease is associated with an offspring's neurodevelopment. We hypothesized that Th-2 biased maternal immune function assessed as total serum immunoglobulin (Ig) E is associated with attention deficit hyperactivity disorder (ADHD). Methods: Data are from the Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study (WHEALS), a racially and socioeconomically diverse birth cohort in metropolitan Detroit, Michigan. Maternal total IgE was measured prenatally and at 1-month postpartum. Child total IgE was assessed at birth, 6 months, and 2 years of age. ADHD diagnosis was based on the parental report at the 10–12-year study visits or medical chart abstraction. Total IgE was log2 transformed. Poisson regression models with robust error variance were used to calculate the risk ratios (RR). Inverse probability weighting was used to correct for potential bias due to a loss to follow-up and non-response. Results: Of the 636 maternal-child pairs in the analysis, 513 children were neurotypical and 123 had ADHD. Maternal prenatal total IgE was significantly associated with ADHD even after adjustment for potential confounders (RR = 1.08, 95% CI 1.03–1.13). Maternal and child IgE measures were positively and significantly correlated, but child total IgE was not associated with ADHD at any time point. Conclusions: Maternal prenatal IgE may influence neurodevelopment, but additional studies are needed to confirm and expand these findings.
KW - attention deficit hyperactivity disorder
KW - cohort study
KW - immunoglobulin E
KW - neurodeveloment
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85107217465&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107217465&partnerID=8YFLogxK
U2 - 10.3389/fped.2021.601092
DO - 10.3389/fped.2021.601092
M3 - Article
AN - SCOPUS:85107217465
SN - 2296-2360
VL - 9
JO - Frontiers in Pediatrics
JF - Frontiers in Pediatrics
M1 - 601092
ER -